vivoVerse
Biotechnology Research • 
Austin, Texas, United States • 11-20 Employees
Company overview
| Headquarters | Austin, Texas, United States |
| Websites | |
| NAICS | 541714 |
| Founded | 2016 |
| Employees | 11-20 |
| Socials |
Key Contacts at vivoVerse
Adela Ben-Yakar
Chief Executive Officer And Co-Founder
Sudip Mondal
Director Of Science
Evan Hegarty
Co-Founder, Principal Investigator, Dir. Of Manufacturing
vivoVerse Email Formats
vivoVerse uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@newormics.com), used 57.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@newormics.com | 57.1% |
{first initial}.{last name} | j.doe@newormics.com | 42.9% |
About vivoVerse
vivoVerse develops and manufactures advanced microfluidics and AI/ML technologies to rapidly and ethically test toxicology/safety profiles of chemicals using C. elegans as a New Approach Methodology (NAM). With a new class of instruments, software, and services, we aim at reducing animal testing.
vivoVerse revenue & valuation
| Annual revenue | $1,026,660 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
vivoVerse has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
vivoVerse has never raised funding before.
Australia
Canada
Czechia
Frequently asked questions
4.8
40,000 users
